Variations across Europe in hospitalization and management of pregnant women with SARS‐CoV ‐2 during the initial phase of the pandemic: Multi‐national population‐based cohort study using the International Network of Obstetric Survey Systems ( INOSS )
Acta Obstetricia et Gynecologica Scandinavica · 2023
DOI: 10.1111/aogs.14643 ↗At a glance
Kohortenstudie in Acta Obstetricia et Gynecologica Scandinavica, 2023. Written by Odette de Bruin and 16 co-authors. Institution: Department of Obstetrics, Birth Center Wilhelmina Children's Hospital, Division Woman and Baby, University Medical Center Utrecht, Utrecht, the Nethe…. Major MEDLINE topics: COVID-19, Pregnancy Complications, Infectious, Venous Thromboembolism. Cited 12 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: Belgian Federal Public Service of Health, EasyTrial, European Medicines Agency.
Abstract (original language)
Introduction
The majority of data on COVID‐19 in pregnancy are not from sound population‐based active surveillance systems. Material and methods We conducted a multi‐national study of population‐based national or regional prospective cohorts using standardized definitions within the International Network of Obstetric Survey systems (INOSS). From a source population of women giving birth between March 1 and August 31, 2020, we included pregnant women admitted to hospital with a positive SARS‐CoV‐2 PCR test ≤7 days prior to or during admission and up to 2 days after birth. The admissions were further categorized as COVID‐19‐related or non‐COVID‐19‐related. The primary outcome of interest was incidence of COVID‐19‐related hospital admission. Secondary outcomes included severe maternal disease (ICU admission and mechanical ventilation) and COVID‐19‐directed medical treatment.
Results
In a source population of 816 628 maternities, a total of 2338 pregnant women were admitted with SARS‐CoV‐2; among them 940 (40%) were COVID‐19‐related admissions. The pooled incidence estimate for COVID‐19‐related admission was 0.59 (95% confidence interval 0.27–1.02) per 1000 maternities, with notable heterogeneity across countries ( I 2 = 97.3%, P = 0.00). In the COVID‐19 admission group, between 8% and 17% of the women were admitted to intensive care, and 5%–13% needed mechanical ventilation. Thromboprophylaxis was the most frequent treatment given during COVID‐19‐related admission (range 14%–55%). Among 908 infants born to women in the COVID‐19‐related admission group, 5 (0.6%) stillbirths were reported.
Conclusions
During the initial months of the pandemic, we found substantial variations in incidence of COVID‐19‐related admissions in nine European countries. Few pregnant women received COVID‐19‐directed medical treatment. Several barriers to rapid surveillance were identified. Investment in robust surveillance should be prioritized to prepare for future pandemics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Obstetrics, Birth Center Wilhelmina Children's Hospital, Division Woman and Baby, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
- Division of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway.
- Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
- National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
- Department of Obstetrics and Gynecology, Copenhagen University Hospital-Holbaek, Holbaek, Denmark.
ORCID profiles: Odette de Bruin, Hilde Engjom, Anna J M Aabakke, Outi Äyräs, Serena Donati, Marian Knight, Evelien M Overtoom, Teresia Svanvik, Kitty W M Bloemenkamp
Funding
- Belgian Federal Public Service of Health
- EasyTrial
- European Medicines Agency
- Finska Läkaresällskapet
- Health Services and Delivery Research Programme
- Helsinki University Central Hospital
- The Nordic Federation of Obstetrics and Gynecology
- The Region of Southern Denmark and Region Zealand
Cite
APA
de Bruin, O., Engjom, H., Vousden, N., Ramakrishnan, R., Aabakke, A. J. M., Äyräs, O., Donati, S., Jónasdóttir, E., Knight, M., Overtoom, E. M., Salvatore, M. A., Sturkenboom, M. C. J. M., Svanvik, T., Varpula, R., Vercoutere, A., Bloemenkamp, K. W. M., & INOSS COVID-19 Working Group (2023). Variations across Europe in hospitalization and management of pregnant women with SARS‐CoV ‐2 during the initial phase of the pandemic: Multi‐national population‐based cohort study using the International Network of Obstetric Survey Systems ( INOSS ). Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14643
Vancouver
de Bruin O, Engjom H, Vousden N, Ramakrishnan R, Aabakke AJM, Äyräs O, et al. Variations across Europe in hospitalization and management of pregnant women with SARS‐CoV ‐2 during the initial phase of the pandemic: Multi‐national population‐based cohort study using the International Network of Obstetric Survey Systems ( INOSS ). Acta Obstetricia et Gynecologica Scandinavica. 2023. doi:10.1111/aogs.14643
BibTeX
@article{deBruin2023,
author = {de Bruin, Odette and Engjom, Hilde and Vousden, Nicola and Ramakrishnan, Rema and Aabakke, Anna J M and Äyräs, Outi and Donati, Serena and Jónasdóttir, Eva and Knight, Marian and Overtoom, Evelien M and Salvatore, Michele A and Sturkenboom, Miriam C J M and Svanvik, Teresia and Varpula, Reetta and Vercoutere, An and Bloemenkamp, Kitty W M and INOSS COVID-19 Working Group, INOSS COVID-19 Working Group},
title = {Variations across Europe in hospitalization and management of pregnant women with SARS‐CoV ‐2 during the initial phase of the pandemic: Multi‐national population‐based cohort study using the International Network of Obstetric Survey Systems ( INOSS )},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2023},
doi = {10.1111/aogs.14643}
}
EUVIMED